Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0002029985-26-000004

Options or other derivatives

  • SVP, CMC & Formulation acquired 85,558 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Tenjarla Srini SVP, CMC & Formulation 2026-05-21 Grant or award · Stock Option (right to buy) +85,558 85,558 D
Loading xslF345X06/wk-form4_1779839080.xml…